Еврооблигации: AbbVie, 0.5% 1jun2021, EUR (FIGI RegS BBG00TTG39P9, XS2117754163, WKN A1VXE9)
Senior Unsecured
Senior Unsecured
|
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including ...
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including multiple sclerosis, parkinson's, and alzheimer's disease.
|
|
|
|
|
|
|
| Following Business Day |
|
|
Откройте глобальную базу данных
1 000 000
облигаций
100 000
акций
183 824
ETF & Funds
100 000
индексов
Отслеживайте свой портфель наиболее эффективным способом
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |